FOLLICULAR LYMPHOMA GRADE 3
Clinical trials for FOLLICULAR LYMPHOMA GRADE 3 explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA GRADE 3 trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA GRADE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR T-Cell therapy targets tough lymphoma cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to recognize and attack cancer cells. The main…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
New antibody therapy aims to prevent lymphoma return after transplant
Disease control Recruiting nowThis early-phase study tests whether adding a drug called mosunetuzumab after a stem cell transplant is safe and doable for people with aggressive B cell lymphoma that has come back or not responded to prior treatments. Mosunetuzumab is an engineered antibody that helps the body'…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for Tough-to-Treat lymphoma: experimental pill shows promise
Disease control Recruiting nowThis study tests an experimental drug called XNW5004 in 65 adults with follicular lymphoma (a slow-growing blood cancer) that has returned or stopped responding after at least three prior treatments. Participants take the drug twice daily for 28-day cycles. Researchers will measu…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3
Phase: PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC